332 related articles for article (PubMed ID: 8685268)
21. Protein phosphatase inhibitors, okadaic acid and calyculin A, induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria.
Murata T; Shirakawa S; Takehara T; Kobayashi S; Haneji T
Biochem Mol Biol Int; 1995 Jun; 36(2):365-72. PubMed ID: 7663440
[TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
[TBL] [Abstract][Full Text] [Related]
23. Inhibition by calyculin A and okadaic acid of the Ca(2+) release-activated Ca(2+) entry pathway in rat basophilic leukemia cells: evidence for regulation by type 1/2A serine/threonine phosphatase activity.
Evans NE; Forth MK; Simpson AK; Mason MJ
Biochim Biophys Acta; 2005 Dec; 1718(1-2):32-43. PubMed ID: 16297373
[TBL] [Abstract][Full Text] [Related]
24. Okadaic acid-induced actin assembly in neutrophils: role of protein phosphatases.
Downey GP; Takai A; Zamel R; Grinstein S; Chan CK
J Cell Physiol; 1993 Jun; 155(3):505-19. PubMed ID: 8388002
[TBL] [Abstract][Full Text] [Related]
25. An inhibitor of protein phosphorylation stops the circadian oscillator and blocks light-induced phase shifting in Gonyaulax polyedra.
Comolli J; Taylor W; Hastings JW
J Biol Rhythms; 1994; 9(1):13-26. PubMed ID: 7949303
[TBL] [Abstract][Full Text] [Related]
26. Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.
Krautheim A; Brechlin P; Becker K; Winkler M; Steinfelder HJ
Br J Pharmacol; 2000 Feb; 129(4):687-94. PubMed ID: 10683193
[TBL] [Abstract][Full Text] [Related]
27. Novel effects on the Gonyaulax circadian system produced by the protein kinase inhibitor staurosporine.
Comolli JC; Hastings JW
J Biol Rhythms; 1999 Feb; 14(1):11-9. PubMed ID: 10036988
[TBL] [Abstract][Full Text] [Related]
28. Okadaic acid-induced decrease in the magnitude and efficacy of the Ca2+ signal in pancreatic beta cells and inhibition of insulin secretion.
Sato Y; Mariot P; Detimary P; Gilon P; Henquin JC
Br J Pharmacol; 1998 Jan; 123(1):97-105. PubMed ID: 9484859
[TBL] [Abstract][Full Text] [Related]
29. NHE3 function and phosphorylation are regulated by a calyculin A-sensitive phosphatase.
Dynia DW; Steinmetz AG; Kocinsky HS
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F745-53. PubMed ID: 20015946
[TBL] [Abstract][Full Text] [Related]
30. Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A.
Yano Y; Sakon M; Kambayashi J; Kawasaki T; Senda T; Tanaka K; Yamada F; Shibata N
Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):439-49. PubMed ID: 7733881
[TBL] [Abstract][Full Text] [Related]
31. Regulation of stimulus-dependent hippocampal acetylcholine release by okadaic acid-sensitive phosphoprotein phosphatases.
Vickroy TW; Malphurs WL; Carriger ML
Neurosci Lett; 1995 May; 191(3):200-4. PubMed ID: 7644146
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60, HL60/ADR and K562 cells.
Sakurada K; Zheng B; Kuo JF
Biochem Biophys Res Commun; 1992 Aug; 187(1):488-92. PubMed ID: 1325792
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of serine/threonine phosphatases enhance phosphorylation of the interferon-gamma receptor while selectively attenuating interferon-gamma-induced gene expression in human peripheral-blood monocytes.
Luong H; Winestock KD; Finbloom DS
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):799-803. PubMed ID: 8192669
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of asialoglycoprotein endocytosis and degradation in rat hepatocytes by protein phosphatase inhibitors.
Holen I; Gordon PB; Strømhaug PE; Berg TO; Fengsrud M; Brech A; Roos N; Berg T; Seglen PO
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):317-26. PubMed ID: 7575471
[TBL] [Abstract][Full Text] [Related]
35. A type-1 phosphoprotein phosphatase from a dinoflagellate as a possible component of the circadian mechanism.
Comolli JC; Fagan T; Hastings JW
J Biol Rhythms; 2003 Oct; 18(5):367-76. PubMed ID: 14582853
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of protein kinases and phosphatases alter root morphology and disorganize cortical microtubules.
Baskin TI; Wilson JE
Plant Physiol; 1997 Feb; 113(2):493-502. PubMed ID: 9046596
[TBL] [Abstract][Full Text] [Related]
37. Phosphoprotein phosphatase activities in rat luteal cells.
Ford SL; Persaud SJ; Jones PM; Abayasekara RE
Biochem Soc Trans; 1995 Feb; 23(1):20S. PubMed ID: 7758730
[No Abstract] [Full Text] [Related]
38. Regulation of natural killer cell-mediated cytotoxicity by serine/threonine phosphatases: identification of a calyculin A-sensitive serine/threonine kinase.
Bajpai A; Brahmi Z
Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):153-9. PubMed ID: 8947480
[TBL] [Abstract][Full Text] [Related]
39. Protein phosphatase inhibitors okadaic acid and calyculin A alter cell shape and F-actin distribution and inhibit stimulus-dependent increases in cytoskeletal actin of human neutrophils.
Kreienbühl P; Keller H; Niggli V
Blood; 1992 Dec; 80(11):2911-9. PubMed ID: 1333304
[TBL] [Abstract][Full Text] [Related]
40. Role of phosphoprotein phosphatases in the corpus luteum: II control of progesterone secretion by isolated rat luteal cells.
Abayasekara DR; Ford SL; Persaud SJ; Jones PM
J Endocrinol; 1996 Aug; 150(2):213-21. PubMed ID: 8869588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]